Response-guided therapy for patients with hepatitis C virus genotype 6 infection: a pilot study

Journal of Viral Hepatitis, 05/17/2012

Treatment with PEG–IFN plus RBV for 24 weeks may be sufficient for patients with genotype 6 who achieve RVR. Prospective randomized trials are required to evaluate this response–guided strategy in a larger number of patients with genotype 6.

Print Article Summary Cat 2 CME Report